Search

Your search keyword '"Mariusz Pytkowski"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Mariusz Pytkowski" Remove constraint Author: "Mariusz Pytkowski" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
58 results on '"Mariusz Pytkowski"'

Search Results

1. The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter

2. Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry

Catalog

Books, media, physical & digital resources

3. Effectiveness and safety of a single freeze strategy of cryoballoon ablation of atrial fibrillation: an EHRA systematic review and meta-analysis

4. The long term risk of lead failure in patients with cardiovascular implantable electronic devices undergoing catheter ablation

5. Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness (AntaEP Study)

6. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation

7. Rhythm or rate control strategy in CRT recipients with long-standing persistent atrial fibrillation - preliminary results of the PilotCRAfT study

8. Utility of a novel 3F coronary sinus catheter during simultaneous ablation of the left anterolateral accessory pathway and left ventricular summit premature ventricular contractions

9. Identification of the ventricular tachycardia circuit using the Advisor HD Grid multielectrode mapping catheter

10. P1463Regional variation in survival rates among primary prevention implantable cardioverter-defibrillator recipients in Eastern and Northern Europe POLKARD Polish ICD Registry perspective

11. P1464A question of gender equality. Sex-related differences in survival after primary prevention implantable cardioverter-defibrillator implantation for dilated cardiomyopathy An analysis from POLKARD

12. P429The efficacy of electrical cardioversion of long-standing persistent or permanent atrial fibrillation in cardiac resynchronization therapy recipients

13. An unexpected outcome of successful radiofrequency ablation for persistent typical atrial flutter lasting 12 years

14. No benefits from exercise training and worse outcomes in heart failure patients with atrial fibrillation and cardiovascular implantable electronic devices

15. Clinical, echocardiographic, and pacing parameters affecting atrial fibrillation burden in patients with tachycardia-bradycardia syndrome

16. Leadless cardiac pacing as the important therapeutic option for the treatment of electrocardiotherapy complications

17. A pacemaker-dependent patient undergoing high-dose stereotactic radiotherapy with the device located in the radiation area

18. P2878Higher all-cause mortality in patients with implanted dual-chamber cardioverter-defibrillators for secondary prevention: an analysis from the Polish ICD Registry

19. P990Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs

20. Comparative effectiveness and safety of antazoline‑based and propafenone‑based strategies for pharmacological cardioversion of short‑duration atrial fibrillation in the emergency department

21. New diagnostic pathways urgently needed. Protocol of PET Guidance I pilot study: positron emission tomography in suspected cardiac implantable electronic device-related infection

22. P6058No benefits of exercise training and worst possible outcomes for heart failure patients with atrial fibrillation and cardiac resynchronization therapy in 54 months follow-up

23. Every percent matters: pitfalls in the mapping and ablation of arrhythmogenic foci arising from the right coronary cusp or right ventricular outflow tract

24. P656Baseline cardiopulmonary exercise test result is the most useful parameter in predicting positive response and long-term survival after cardiac resynchronization therapy

25. P2697Utility of antazoline for cardioversion of recent onset atrial fibrillation in patients with a history of myocardial infarction

26. Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks

27. The effectiveness of transvenous leads extractions implanted more than 10 years before

28. Novel algorithm for arrhythmogenic focus localization in patients with right ventricular outflow tract arrhythmias

29. Translation and cultural adaptation of a Patient Perception of Arrhythmia Questionnaire in Poland

30. Long‐term risk of cardiovascular implantable electronic device–related infection after catheter ablation of arrhythmia

31. Potential Prevention of Pacing-Induced Heart Failure Using Simple Pacemaker Programming Algorithm

32. Quality of life improvement after radiofrequency catheter ablation of outfl ow tract ventricular arrhythmias in patients with structurally normal hearts

34. Clinical effectiveness and safety of antazoline‐based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short‐duration atrial fibrillation in the emergency department

35. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay

36. Subacute cardiac perforations associated with active fixation leads

37. Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation

38. Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation

39. P1451Clinical and pacing parameters related to atrial fibrillation in patients with tachycardia-bradycardia syndrome

40. P298Intravenous antazoline for cardioversion of recent onset atrial fibrillation in patients with stable coronary artery disease

41. Comparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of Cardiac Resynchronization in Atrial Fibrillation Trial (Pilot-CRAfT): study protocol for a randomized controlled trial

42. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study

43. Utility of automated template matching for the interpretation of pace mapping in patients ablated due to outflow tract ventricular arrhythmias

44. Economical aspect of PET/CT-guided diagnosis of suspected infective endocarditis in a patient with implantable cardioverter-defibrillator

45. Effectiveness of antitachycardia pacing therapy after primary prophylaxis implantation of implantable defibrillators in coronary artery disease patients

46. Radiofrequency ablation of numerous premature ventricular contractions in a cardiac resynchronisation therapy patient: a long-term follow-up

47. Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long-Term Follow-up

48. Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy

49. Epicardial electric shock ablation of the left lateral accessory pathway